Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients S Facchin, A Buda, R Cardin, N Agbariah, F Zingone, M De Bona, ... Therapeutic Advances in Gastroenterology 14, 1756284821999902, 2021 | 19 | 2021 |
Immune-mediated thrombotic thrombocytopenic purpura following mRNA-based COVID-19 vaccine BNT162b2: case report and mini-review of the literature VA Buetler, N Agbariah, DP Schild, FD Liechti, A Wieland, N Andina, ... Frontiers in medicine 9, 890661, 2022 | 6 | 2022 |
Acquired immune-mediated thrombotic thrombocytopenic pur-pura (iTTP) following mRNA-based COVID-19 vaccination (BNT162b2) N Agbariah, VA Bütler, A Wieland, N Andina, F Hammann, ... Swiss Medical Weekly, 20S-20S, 2021 | 3 | 2021 |
“A Dangerous Black Box:” Idiopathic Hemophagocytic Lymphohistiocytosis in Adult Patients—A Case Report and Review of the Literature N Agbariah, J Sanz, A Rovó Case reports in hematology 2022 (1), 5867129, 2022 | 2 | 2022 |
P475 rapid point-of-care anti-drug antibodies measurement correlates with standardised T tests and facilitate a proactive therapeutic drug monitoring approach in IBD patients … S Facchin, A Buda, R Cardin, R D'Incà, F Zingone, N Agbariah, ... Journal of Crohn's and Colitis 13 (Supplement_1), S349-S350, 2019 | 2 | 2019 |
Breaking Stereotypes: Polycythemia Secondary to Shisha Smoking in a Middle-Age Swiss Woman N Agbariah, A Rovó Acta haematologica 145 (6), 650-654, 2022 | | 2022 |
P. 07.28 PREVIOUS EXPOSURE TO INFLIXIMAB INDUCES CROSS-REACTIVITY AND AFFECTS ADALIMUMAB TROUGH LEVELS: DATA FROM A PROSPECTIVE, MULTICENTRE STUDY S Facchin, N Agbariah, A Buda, R Cardin, F Zingone, R D'Incà, ... Digestive and Liver Disease 51, e234, 2019 | | 2019 |